CLOV in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with CLOV today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Clover Health Investments, Corp. provides health insurance to people eligible for Medicare, the U.S. federal health insurance program. Almost all its revenue comes from Medicare Advantage premiums paid monthly by the Centers for Medicare & Medicaid Services (CMS). Clover pays members’ medical claims and administrative expenses from those premiums. Most members live in New Jersey, so local healthcare costs and competition matter especially to the business.
Clover gives primary-care clinicians its Clover Assistant software, which brings together patient data and suggests personalized care during visits. It pays clinicians higher rates for visits using the platform. Its economics depend on retaining members and on clinicians using the software and clinical programs to help manage medical costs. Subsidiary Counterpart Health also offers the software externally as Counterpart Assistant to insurers and healthcare providers, but this business is not yet a significant contributor.
Government payment rules, including adjustments for members’ health profiles, shape Clover’s revenue. Medicare Advantage rules require it to spend most premiums on healthcare, covered benefits and quality improvement. Its insurance subsidiaries must also maintain state licenses and minimum capital, and regulators restrict transfers of funds to the parent company.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Clover's results hinge on CMS Medicare Advantage payments, Star ratings and medical costs, with Aetna another important rival to watch outside this list.
Alignment Healthcare and Clover compete for seniors choosing Medicare Advantage plans, and both use their own clinical software to manage care and medical costs. CMS pays Alignment a monthly amount per member, making its Star ratings and care costs useful comparisons for Clover's insurance business.
Humana and Clover both sell Medicare Advantage insurance to seniors and pay for members' covered care, exposing them to the same pressures from reimbursement and medical costs. Watch Humana's Medicare insurance enrollment and care costs rather than treating its CenterWell pharmacy, primary-care and home-health results as a direct comparison.
UnitedHealth competes with Clover in Medicare Advantage insurance and in using technology to manage patient care. Its Optum Health business accepts monthly premiums in exchange for taking responsibility for healthcare costs, making those arrangements a useful comparison for the economics of managing care—not a direct measure of Clover's software revenue.
Centene competes with Clover in Medicare Advantage coverage, but its larger Medicaid and Marketplace insurance businesses make its overall results a less direct comparison. Medicare accounted for 19% of Centene's total external revenue in 2025, so its Medicare results are more relevant to Clover than the group total.
Elevance Health competes with Clover in Medicare Advantage insurance, where reimbursement and covered medical costs matter to both. Its employer insurance, fees for administering employers' health plans and Carelon health-service revenue broaden the business, so focus on Medicare Advantage news when judging what its results mean for Clover.
Molina Healthcare and Clover both provide Medicare managed-care coverage, collecting premiums and bearing the cost of covered care. Medicaid generated 75% of Molina's consolidated premium revenue in 2025, so its Medicare care costs are a closer comparison for Clover than its overall premium growth.
Alignment Healthcare, Inc. earningsALHC
Alignment Healthcare’s report will show how its Medicare Advantage enrollment and care costs are changing, offering Clover Health a read on competition and cost pressure in the same market.
Focus on Alignment’s Medicare Advantage enrollment and care costs, not its overall results as a stand-in for Clover Health. Stable enrollment with controlled costs would show that plans in this market can still attract seniors and manage care spending. Falling enrollment or rising costs would point to greater difficulty winning members or limiting claims, pressures Clover also faces.
Clover Health Investments, Corp earningsThis company
Clover Health uses Medicare Advantage premiums to pay members’ medical claims, and this report will show whether premiums are still growing faster than those claims and leaving profit in its insurance business.
Read net premiums alongside medical claims and insurance gross profit. If premiums grow faster than claims and gross profit holds, added members and care-cost control are not eating up premium growth. If claims grow faster and gross profit narrows, less of each premium dollar remains to support operating costs as the business expands.